Barclays’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.9M | Buy |
183,700
+70,300
| +62% | +$16.4M | 0.01% | 766 |
|
|
2025
Q4 | $23.5M | Sell |
113,400
-15,700
| -12% | -$3.1M | 0.01% | 1163 |
|
|
2025
Q3 | $23.9M | Buy |
129,100
+32,500
| +34% | +$5.57M | 0.01% | 1126 |
|
|
2025
Q2 | $14.8M | Sell |
96,600
-1,034,900
| -91% | -$159M | ﹤0.01% | 1305 |
|
|
2025
Q1 | $188M | Buy |
1,131,500
+1,081,500
| +2,163% | +$169M | 0.05% | 266 |
|
|
2024
Q4 | $7.23M | Hold |
50,000
| – | – | ﹤0.01% | 1833 |
|
|
2024
Q3 | $8.1M | Sell |
50,000
-71,600
| -59% | -$11.4M | ﹤0.01% | 1638 |
|
|
2024
Q2 | $17.8M | Buy |
121,600
+78,200
| +180% | +$11.6M | 0.01% | 977 |
|
|
2024
Q1 | $6.87M | Sell |
43,400
-49,600
| -53% | -$7.89M | ﹤0.01% | 1647 |
|
|
2023
Q4 | $14.6M | Buy |
+93,000
| New | +$14.3M | 0.01% | 1245 |
|
|
2023
Q2 | – | Sell |
-54,200
| Closed | -$8.4M | – | 4798 |
|
|
2023
Q1 | $8.4M | Sell |
54,200
-33,000
| -38% | -$5.33M | ﹤0.01% | 1250 |
|
|
2022
Q4 | $15.4M | Buy |
87,200
+76,600
| +723% | +$13.2M | 0.01% | 1010 |
|
|
2022
Q3 | $1.73M | Buy |
+10,600
| New | +$1.79M | ﹤0.01% | 1849 |
|
|
2021
Q4 | – | Sell |
-15,000
| Closed | -$2.42M | – | 4472 |
|
|
2021
Q3 | $2.42M | Buy |
+15,000
| New | +$2.56M | ﹤0.01% | 2184 |
|
|
2021
Q1 | – | Sell |
-400,700
| Closed | -$63.1M | – | 4958 |
|
|
2020
Q4 | $63.1M | Buy |
400,700
+249,200
| +164% | +$36.8M | 0.03% | 384 |
|
|
2020
Q3 | $22.6M | Sell |
151,500
-9,300
| -6% | -$1.38M | 0.01% | 700 |
|
|
2020
Q2 | $22.6M | Buy |
160,800
+46,100
| +40% | +$6.72M | 0.02% | 601 |
|
|
2020
Q1 | $15M | Sell |
114,700
-118,100
| -51% | -$16.8M | 0.01% | 773 |
|
|
2019
Q4 | $34M | Buy |
232,800
+67,100
| +40% | +$9.1M | 0.02% | 677 |
|
|
2019
Q3 | $21.4M | Sell |
165,700
-101,900
| -38% | -$13.4M | 0.01% | 844 |
|
|
2019
Q2 | $37.3M | Sell |
267,600
-44,400
| -14% | -$6.15M | 0.02% | 604 |
|
|
2019
Q1 | $43.6M | Sell |
312,000
-134,800
| -30% | -$18.1M | 0.03% | 490 |
|
|
2018
Q4 | $57.7M | Buy |
446,800
+72,500
| +19% | +$10.1M | 0.04% | 332 |
|
|
2018
Q3 | $51.7M | Buy |
374,300
+101,500
| +37% | +$13.5M | 0.04% | 397 |
|
|
2018
Q2 | $33.1M | Buy |
272,800
+90,900
| +50% | +$11.3M | 0.03% | 535 |
|
|
2018
Q1 | $23.3M | Sell |
181,900
-166,100
| -48% | -$22.5M | 0.02% | 779 |
|
|
2017
Q4 | $48.6M | Buy |
348,000
+150,100
| +76% | +$20.9M | 0.04% | 426 |
|
|
2017
Q3 | $25.7M | Buy |
197,900
+126,100
| +176% | +$16.7M | 0.03% | 560 |
|
|
2017
Q2 | $9.5M | Sell |
71,800
-17,800
| -20% | -$2.27M | 0.01% | 1009 |
|
|
2017
Q1 | $11.2M | Sell |
89,600
-516,000
| -85% | -$61.6M | 0.01% | 818 |
|
|
2016
Q4 | $69.8M | Sell |
605,600
-256,500
| -30% | -$29.6M | 0.08% | 206 |
|
|
2016
Q3 | $102M | Buy |
862,100
+454,300
| +111% | +$55.1M | 0.11% | 134 |
|
|
2016
Q2 | $49.5M | Buy |
407,800
+35,200
| +9% | +$4M | 0.06% | 260 |
|
|
2016
Q1 | $40.2M | Sell |
372,600
-244,300
| -40% | -$25.3M | 0.06% | 265 |
|
|
2015
Q4 | $62.9M | Sell |
616,900
-332,400
| -35% | -$33.4M | 0.08% | 221 |
|
|
2015
Q3 | $88.3M | Buy |
949,300
+166,700
| +21% | +$16.1M | 0.11% | 164 |
|
|
2015
Q2 | $75.9M | Sell |
782,600
-378,100
| -33% | -$37.9M | 0.09% | 197 |
|
|
2015
Q1 | $116M | Buy |
1,160,700
+145,800
| +14% | +$14.8M | 0.13% | 131 |
|
|
2014
Q4 | $106M | Sell |
1,014,900
-257,700
| -20% | -$27.2M | 0.1% | 161 |
|
|
2014
Q3 | $135M | Sell |
1,272,600
-12,300
| -1% | -$1.28M | 0.13% | 113 |
|
|
2014
Q2 | $134M | Sell |
1,284,900
-90,200
| -7% | -$9.12M | 0.14% | 101 |
|
|
2014
Q1 | $135M | Sell |
1,375,100
-377,200
| -22% | -$35M | 0.15% | 109 |
|
|
2013
Q4 | $159M | Sell |
1,752,300
-1,112,400
| -39% | -$103M | 0.16% | 81 |
|
|
2013
Q3 | $246M | Sell |
2,864,700
-333,200
| -10% | -$29.9M | 0.29% | 35 |
|
|
2013
Q2 | $275M | Buy |
+3,197,900
| New | +$271M | 0.34% | 34 |
|
Other funds holding JNJ
VCM
VPM
Barclays's JNJ Position: Q1 2026 in Review
Barclays increased its Johnson & Johnson (JNJ) stake by 52% in Q1 2026, buying an estimated $543M and bringing the position to 6,786,107 shares worth $1.66B. The position accounts for 0.4% of the portfolio, ranked #28.
Barclays first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.98B in Q4 2022. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Barclays held 6,786,107 shares of Johnson & Johnson worth $1.66B as of Q1 2026.
- Barclays bought 2,330,946 Johnson & Johnson shares in Q1 2026, an estimated $543M.
- Johnson & Johnson made up 0.4% of Barclays's portfolio in Q1 2026, its #28 holding.
- Barclays first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- Barclays's Johnson & Johnson position peaked at $1.98B in Q4 2022.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.